AI assistant
Sending…
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012
Sep 6, 2012
29864_dirs_2012-09-06_4f45d25d-16b4-4834-8d07-923985cd2fd2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-09-04
Reporting Person: Arbuckle Stuart A (EVP\Chief Commercial Officer)
More from VERTEX PHARMACEUTICALS INC / MA
Major Shareholding Notification
2026
May 14
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 13